Abivax (AAVXF) Shares Outstanding (Diluted Average) (2021 - 2025)

Abivax has reported Shares Outstanding (Diluted Average) over the past 5 years, most recently at $80.9 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $80.9 million for Q4 2025, up 20.13% from a year ago — trailing twelve months through Dec 2025 was $80.9 million (up 20.13% YoY), and the annual figure for FY2025 was $78.6 million, up 15.12%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $80.9 million at Abivax, up from $67.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for AAVXF hit a ceiling of $80.9 million in Q4 2025 and a floor of $17.7 million in Q4 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $46.3 million (2023), compared with a mean of $46.4 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): rose 10.17% in 2022 and later surged 137.88% in 2023.
  • Abivax's Shares Outstanding (Diluted Average) stood at $17.7 million in 2021, then grew by 10.17% to $19.5 million in 2022, then surged by 137.88% to $46.3 million in 2023, then soared by 45.4% to $67.4 million in 2024, then grew by 20.13% to $80.9 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $80.9 million (Q4 2025), $67.4 million (Q4 2024), and $46.3 million (Q4 2023) per Business Quant data.